Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility

Immunology Letters

Volumn 147, Issue 1-2, 2012, Pages 10-17

  Choubey, Divaker ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ifi200 family genes; Interferons; Lupus susceptibility; Nba2 locus; Sex hormones

Indexed keywords

CD150 ANTIGEN; INTERFERON REGULATORY FACTOR 5; P202 PROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

AIM2 GENE; CYTOKINE PRODUCTION; FCGR2B GENE; FCYR2B GENE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; IFI16 GENE; INTERFERON INDUCIBLE 200 FAMILY GENE; INTERFERON INDUCIBLE 202 GENE; IRF5 GENE; NBA2 GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE GENE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, CD; AUTOIMMUNITY; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION; GENES, MODIFIER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEAR PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, IGG;

EID: 84865394537     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.07.003     Document Type: Review

References (111)

1. Tsokos G.C. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110-2121.
2. Liu Z., Davidson A. Taming lupus - a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012, 18:871-882.
3. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
4. Deng Y., Tsao B.P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010, 6:683-692.
5. Kotzin B.L. Systemic lupus erythematosus. Cell 1996, 85:303-306.
6. Morel L. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 2010, 6:348-357.
7. Rönnblom L., Pascual V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus 2008, 17:394-399.
8. Muñoz L.E., Lauber K., Schiller M., Manfredi A.A., Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010, 6:280-289.
9. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
10. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.
11. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. J Autoimmun 2012, 38:J282-J291.
12. Choubey D., Panchanathan R., Duan X., Liu H., Liu H. Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. J Interferon Cytokine Res 2011, 31:893-906.
13. Wu T., Qin X., Kurepa Z., Kumar K.R., Liu K., Kanta H., et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 2007, 117:2186-2196.
14. Singh R.P., Waldron R.T., Hahn B.H. Genes, tolerance and systemic autoimmunity. Autoimmun Rev 2012, 11:664-669.
15. Moser K.L., Kelly J.A., Lessard C.J., Harley J.B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009, 10:373-379.
16. Salloum R., Niewold T.B. Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011, 157:326-331.
17. Crow M.K. Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am 2010, 36:173-186.
18. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005, 23:307-336.
19. Niewold T.B. Interferon alpha as a primary pathogenic factor in human lupus. J Interferon Cytokine Res 2011, 31:887-892.
20. Vyse T.J., Kotzin B.L. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998, 16:261-292.
21. Kono D.H., Theofilopoulos A.N. Genetics of systemic autoimmunity in mouse models of lupus. Int Rev Immunol 2000, 19:367-387.
22. Pathak S., Mohan C. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res Ther 2011, 13:241.
23. Rozzo S.J., Allard J.D., Choubey D., Vyse T.J., Izui S., Peltz G., et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001, 15:435-443.
24. Choubey D., Kotzin B.L. Interferon-inducible p202 in the susceptibility to systemic lupus. Front Biosci 2002, 7:e252-e262.
25. 1 mice. Genes Immun 2007, 8:653-662.
26. Jørgensen T.N., Thurman J., Izui S., Falta M.T., Metzger T.E., Flannery S.A., et al. Genetic susceptibility to polyI:C-induced IFN-α/β-dependent accelerated disease in lupus-prone mice. Genes Immun 2006, 7:555-567.
27. Santiago-Raber M.L., Kikuchi S., Borel P., Uematsu S., Akira S., Kotzin B.L., et al. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 2008, 181:1556-1562.
28. Stohl W., Xu D., Kim K.S., Koss M.N., Jorgensen T.N., Deocharan B., et al. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum 2005, 52:2080-2091.
29. Gubbels M.R., Jørgensen T.N., Metzger T.E., Menze K., Steele H., Flannery S.A., et al. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. J Immunol 2005, 175:6190-6196.
30. Vyse T.J., Rozzo S.J., Drake C.G., Izui S., Kotzin B.L. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J Immunol 1997, 158:5566-5574.
31. Kikuchi S., Fossati-Jimack L., Moll T., Amano H., Amano E., Ida A., et al. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis. J Immunol 2005, 174:1111-1117.
32. Choubey D., Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett 2008, 119:32-41.
33. Jørgensen T.N., Gubbels M.R., Kotzin B.L. New insights into disease pathogenesis from mouse lupus genetics. Curr Opin Immunol 2004, 16:787-793.
34. Jørgensen T.N., Alfaro J., Enriquez H.L., Jiang C., Loo W.M., Atencio S., et al. Development of murine lupus involves the combined genetic contribution of the SLAM and FcγR intervals within the Nba2 autoimmune susceptibility locus. J Immunol 2010, 184:775-786.
35. Choubey D., Panchanathan R., Shen H., Duan X. Comment on "Development of murine lupus involves the combined genetic contribution of the SLAM and Fc gamma R intervals within the Nba2 autoimmune susceptibility locus" J Immunol 2010, 184:4051-4052.
36. Boross P., Arandhara V.L., Martin-Ramirez J., Santiago-Raber M.L., Carlucci F., Flierman R., et al. The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. J Immunol 2011, 187:1304-1313.
37. Choubey D., Panchanathan R., Liu H. Comment on "The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility" J Immunol 2011, 187:3909.
38. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010, 11:395-402.
39. Choubey D., Duan X., Dickerson E., Ponomareva L., Panchanathan R., Shen H., et al. Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J Interferon Cytokine Res 2010, 30:371-380.
40. Johnstone R.W., Trapani J.A. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 1999, 19:5833-5838.
41. Deschamps S., Meyer J., Chatterjee G., Wang H., Lengyel P., Roe B.A. The mouse Ifi200-gene cluster: genomic sequence, analysis, and comparison with the human HIN-200 gene cluster. Genomics 2003, 82:34-46.
42. Asefa B., Klarmann K.D., Copeland N.G., Gilbert D.J., Jenkins N.A., Keller J.R. The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis 2004, 32:155-167.
43. Mondini M., Costa S., Sponza S., Gugliesi F., Gariglio M., Landolfo S. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity 2010, 43:226-231.
44. Wang H., Chatterjee G., Meyer J.J., Liu C.J., Manjunath N.A., Bray-Ward P., et al. Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster. Genomics 1999, 60:281-294.
45. Choubey D., Gutterman J.U. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain. Biochem Biophys Res Commun 1996, 221:396-401.
46. Roberts T.L., Idris A., Dunn J.A., Kelly G.M., Burnton C.M., Hodgson S., et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009, 323:1057-1060.
47. Liao J.C., Lam R., Brazda V., Duan S., Ravichandran M., Ma J., et al. Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53. Structure 2011, 19:418-429.
48. Schattgen S.A., Fitzgerald K.A. The PYHIN protein family as mediators of host defenses. Immunol Rev 2011, 243:109-118.
49. Veeranki S., Choubey D. Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol Immunol 2012, 49:567-571.
50. Choubey D., Pramanik R., Xin H. Subcellular localization and mechanisms of nucleocytoplasmic distribution of p202, an interferon-inducible candidate for lupus susceptibility. FEBS Lett 2003, 553:245-249.
51. Choubey D., Lengyel P. Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi200 gene from the gene 200-cluster. J Interferon Res 1993, 13:43-52.
52. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
53. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
54. Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
55. Bürckstümmer T., Baumann C., Blüml S., Dixit E., Dürnberger G., Jahn H., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009, 10:266-272.
56. Kis-Toth K., Szanto A., Thai T.H., Tsokos G.C. Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response. J Immunol 2011, 187:1222-1234.
57. Yamauchi M., Hashimoto M., Ichiyama K., Yoshida R., Hanada T., Muta T., et al. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-κB activation in dendritic cells. Int Immunol 2007, 19:935-942.
58. Gee K., Guzzo C., Che Mat N.F., Ma W., Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 2009, 8:40-52.
59. Ludlow L.E., Purton L.E., Klarmann K., Gough D.J., Hii L.L., Trapani J.A., et al. The role of p202 in regulating hematopoietic cell proliferation and differentiation. J Interferon Cytokine Res 2008, 28:5-11.
60. Chen J., Panchanathan R., Choubey D. Stimulation of T cells up-regulates expression of Ifi202, an interferon-inducible lupus susceptibility gene, through activation of JNK/c-Jun pathway. Immunol Lett 2008, 118:13-20.
61. Zimmerman M., Yang D., Hu X., Liu F., Singh N., Browning D., et al. IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells. PLoS One 2010, 5:e14076.
62. Panchanathan R., Duan X., Arumugam M., Shen H., Liu H., Choubey D. Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Mol Immunol 2011, 49:273-280.
63. Panchanathan R., Liu H., Liu H., Fang C.M., Erickson L.D., Pitha P.M., et al. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J Immunol 2012, 188:270-278.
64. Panchanathan R., Xin H., Choubey D. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice. J Immunol 2008, 180:5927-5934.
65. Xin H., D'Souza S., Jørgensen T.N., Vaughan A.T., Lengyel P., Kotzin B.L., et al. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol 2006, 176:5863-5870.
66. Min W., Ghosh S., Lengyel P. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol 1996, 16:359-368.
67. Wang H., Liu C., Lu Y., Chatterjee G., Ma X.Y., Eisenman R.N., et al. The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. J Biol Chem 2000, 275:27377-27385.
68. Ma X.Y., Wang H., Ding B., Zhong H., Ghosh S., Lengyel P. The interferon-inducible p202a protein modulates NF-κB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J Biol Chem 2003, 278:23008-23019.
69. Panchanathan R., Shen H., Bupp M.G., Gould K.A., Choubey D. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol 2009, 183:7031-7038.
70. Santiago-Raber M.L., Baccala R., Haraldsson K.M., Choubey D., Stewart T.A., Kono D.H., et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003, 197:777-788.
71. Pramanik R., Jørgensen T.N., Xin H., Kotzin B.L., Choubey D. Interleukin-6 induces expression of Ifi202, an interferon-inducible candidate gene for lupus susceptibility. J Biol Chem 2004, 279:16121-16127.
72. Choubey D. p202: an interferon-inducible negative regulator of cell growth. J Biol Regul Homeost Agents 2000, 14:187-192.
73. Dodson R.E., Shapiro D.J. An estrogen-inducible protein binds specifically to a sequence in the 3' untranslated region of estrogen-stabilized vitellogenin mRNA. Mol Cell Biol 1994, 14:3130-3138.
74. Koul D., Obeyesekere N.U., Gutterman J.U., Mills G.B., Choubey D. p202 self-associates through a sequence conserved among the members of the 200-family proteins. FEBS Lett 1998, 438:21-24.
75. Datta B., Li B., Choubey D., Nallur G., Lengyel P. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J Biol Chem 1996, 271:27544-27555.
76. Liu C., Wang H., Zhao Z., Yu S., Lu Y.B., Meyer J., et al. MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon. Mol Cell Biol 2000, 20:7024-7036.
77. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008, 8:34-47.
78. Smith K.G., Clatworthy M.R. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010, 10:328-343.
79. Jiang Y., Hirose S., Sanokawa-Akakura R., Abe M., Mi X., Li N., et al. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 1999, 11:1685-1691.
80. Jiang Y., Hirose S., Abe M., Sanokawa-Akakura R., Ohtsuji M., Mi X., et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000, 51:429-435.
81. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285.
82. (-/-) mice. J Exp Med 2002, 195:1167-1174.
83. McGaha T.L., Karlsson M.C., Ravetch J.V. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol 2008, 180:5670-5679.
84. Panchanathan R., Shen H., Duan X., Rathinam V.A., Erickson L.D., Fitzgerald K.A., et al. Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein. J Immunol 2011, 186:6762-6770.
85. Dhodapkar K.M., Banerjee D., Connolly J., Kukreja A., Matayeva E., Veri M.C., et al. Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med 2007, 204:1359-1369.
86. Wang A., Batteux F., Wakeland E.K. The role of SLAM/CD2 polymorphisms in systemic autoimmunity. Curr Opin Immunol 2010, 22:706-714.
87. Detre C., Keszei M., Romero X., Tsokos G.C., Terhorst C. SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions. Semin Immunopathol 2010, 32:157-171.
88. Cannons J.L., Tangye S.G., Schwartzberg P.L. SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 2011, 29:665-705.
89. Chatterjee M., Rauen T., Kis-Toth K., Kyttaris V.C., Hedrich C.M., Terhorst C., et al. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J Immunol 2012, 188:1206-1212.
90. Kumar K.R., Li L., Yan M., Bhaskarabhatla M., Mobley A.B., Nguyen C., et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006, 312:1665-1669.
91. Chatterjee M., Kis-Toth K., Thai T.H., Terhorst C., Tsokos G.C. SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells. Autoimmunity 2011, 44:211-218.
92. Wang N., Satoskar A., Faubion W., Howie D., Okamoto S., Feske S., et al. The cell surface receptor SLAM controls T cell and macrophage functions. J Exp Med 2004, 199:1255-1264.
93. -/- [BALB/c.129] mice. Int Immunol 2011, 23:149-158.
94. Howie D., Okamoto S., Rietdijk S., Clarke K., Wang N., Gullo C., et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood 2002, 100:2899-2907.
95. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245.
96. D'Souza S., Xin H., Walter S., Choubey D. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J Biol Chem 2001, 276:298-305.
97. Jordan M.A., Fletcher J.M., Jose R., Chowdhury S., Gerlach N., Allison J., et al. Role of SLAM in NKT cell development revealed by transgenic complementation in NOD mice. J Immunol 2011, 186:3953-3965.
98. Panchanathan R., Duan X., Shen H., Rathinam V.A., Erickson L.D., Fitzgerald K.A., et al. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J Immunol 2010, 185:7385-7393.
99. Jones J.W., Kayagaki N., Broz P., Henry T., Newton K., O'Rourke K., et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A 2010, 107:9771-9776.
100. Kozyrev S.V., Alarcon-Riquelme M.E. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 2007, 40:591-601.
101. Barnes B., Lubyova B., Pitha P.M. On the role of IRF in host defense. J Interferon Cytokine Res 2002, 22:59-71.
102. Lien C., Fang C.M., Huso D., Livak F., Lu R., Pitha P.M. Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A 2010, 107:4664-4668.
103. Martins G., Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008, 26:133-169.
104. Savitsky D.A., Yanai H., Tamura T., Taniguchi T., Honda K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci U S A 2010, 107:10154-10159.
105. Shen H., Panchanathan R., Rajavelu P., Duan X., Gould K.A., Choubey D. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J Mol Cell Biol 2010, 2:284-290.
106. Mondini M., Vidali M., Airò P., De Andrea M., Riboldi P., Meroni P.L., et al. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann N Y Acad Sci 2007, 1110:47-56.
107. Choubey D., Deka R., Ho S.M. Interferon-inducible IFI16 protein in human cancers and autoimmune diseases. Front Biosci 2008, 13:598-608.
108. Kimkong I., Avihingsanon Y., Hirankarn N. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR. Lupus 2009, 18:1066-1072.
109. Duan X., Ponomareva L., Veeranki S., Panchanathan R., Dickerson E., Choubey D. Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts. Mol Cancer Res 2011, 9:589-602.
110. Flinn L.J. Genomic analysis of a human interferon-inducible gene family and systemic lupus erythematosus. J Interferon Cytokine Res 2007, 27:828.
111. Choubey D. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin Immunol 2012, 142:223-231.